In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/10929022

Download in:

View as

General Info

PMID
10929022